The onset of symptoms in dystrophic chickens occurs in the second month after hatching. Chickens are unable to right themselves when placed on their backs, and their wings become excessively stiff and eventually cannot be elevated beyond a horizontal plane. Penicillamine treat- The number of successful rightings out ofa total offour trials (see text) were recorded over a period of 105 days. The mean values for the males 1 SEM are shown ment of dystrophic chickens delays the onset of symptoms and partially alleviates the debilitating aspects of the disease. The drug also counteracts abnormalities in enzyme levels and returns the catalytic activity to more normal values.
The rationale behind penicillamine treatment was twofold: (1) To alter the intracellular redox status, thereby preventing oxidation of critical sulphydryl groups of enzymes, and (2) to decrease the formation of crosslinked, insoluble collagen in muscle. Our experimental results to date will be presented and then discussed with regard to the proposed rationale and mechanism of therapeutic action.
Methods and Results
Newly hatched chicks were a gift from Dr Louis Pierro, University of Connecticut at Storrs. The dystrophic chicks were matched and divided into two groups, an untreated and a penicillaminetreated group. Normal white leghorn chicks were purchased locally and divided into similar untreated and treated groups. There were 7 untreated and 8 treated dystrophic chicks, as well as 9 untreated and 10 treated normal birds in the experimental, groups. The experiment was designed as a double-blind study with one investigator administering either penicillamine or a water placebo to the birds. Two other investigators, who had no knowledge of the experimental grouping, performed the functional tests on the birds.
Penicillamine treatment was not begun until the 9th day after hatching to ensure that the chicks had regained their normal health after possible injury during transportation. The drug was prepared for administration from capsules of D-penicillamine (Ciprimine) obtained from Merck, Sharp and Dohme. A solution of penicillamine was administered orally with an automatic pipette. The daily dose was regulated according to body weight and general health, as indicated by inactivity, loose stools or vomiting. Up to 50 days' of age the birds could tolerate as much as 200 mg/kg per day. By four months the adult dose was about 100 mg/kg per day. In the course of time, the dose dropped to 50 mg/kg per day, which is approximately the level Used in the treatment of patients with cystiriuria.
Three methods are presented for evaluating the effects of penicillamine treatment: (I) Righting ability, (2) wing apposition, and (3) CPK levels in the plasma. Since the general conclusions were the same for both the males and females (Chou et al. 1975) , only the actual data for the roosters will be presented. has wings that can easily be approximated. The untreated male (B) has stiff wings with a distance offive inches between the styloidprocesses ofthe radii
Righting ability: The righting ability was tested as follows: The bird was placed on its back and, if a bird could not rise, it was allowed to flap until exhausted. Two righting trials were done consecutively, followed by the measurements of body weight and wing apposition. Then two more trials for righting were performed. The total number of successful trials was recorded for each chicken, and the average values are plotted in Fig 1. Normal chickens can right themselves immediately when placed on their backs on a flat surface. Dystrophic birds show some difficulty in rising at about 30 to 40 days of age. At approximately 50 days, striking effects of penicillamine treatment were observed. The untreated males were unable to right whereas penicillaminetreated males could right themselves on the average more than 70% of the time. The data were statistically analysed and the standard error of the mean plotted in Fig 1. Using Student's t test, penicillamine-treated males showed significantly better righting during the last 2j months of the experiment. P values of less than 0.05 were observed for measurements on 17 out of 21 days. Normal chickens, both treated and untreated, were able to right themselves successfully on all four trials throughout the entire experiment. Therefore, the data for these birds were not plotted in Fig 1. Wing apposition: Wing apposition was measured by raising the wings vertically until the styloid processes of the radii touched. If contractures prevented apposition, the distance between the styloid processes was measured in inches. Independent observers could readily reproduce the results, and typical measurements are shown in Fig 2 A, B . The wing apposition and righting tests were performed twice a week, but for simplification of the graphs (Figs 1 and 3) , only the points at one-week intervals are plotted.
In normal chickens, the two wings can be raised vertically without any resistance until they touch each other (Fig 2A) . During the first month the measurement of the distance between the raised wings of the dystrophic chicks was essentially zero, indicating perfect flexibility (Fig 3) . Subsequently, untreated males showed the greatest rigidity, with an average of 5.2 inches between the wings by the third month. Penicillamine treatment partially alleviated the stiffness, as shown by the final distance of 2.0 inches in the treated males. The treatment produced a statistically significant improvement in wing flexibility during the last month on eight out of nine testing days, as indicated by P values less than 0.05.
The wings of all normal chickens were easily approximated throughout the entire experiment. The distance between the wings ofdystrophic male birds was measured as described in the text. Each point represents the mean valuefor wing distance ± SEM groups (P value, 5 x 10-6). Glutathione, cysteine, or other small molecules did not interfere with these determinations since assays of the supernatants following trichloroacetic acid precipitation of proteins showed no detectable sulphydryl content.
By contrast, dystrophic red muscle (thigh) had 58% of the normal amount of SH residues per gram of muscle (P value, 0.01). The sulphydryl groups per mg of protein were not significantly different in dystrophic and normal red muscles. Thus there was no preferential loss of proteins with SH residues. The results are in accordance with the fact that red muscle is less severely affected than white muscle in avian dystrophy.
These determinations demonstrate the extent of the deficiencies in sulphydryl proteins in dystrophic muscles. In recent preliminary studies, we have shown that penicillamine treatment raises the SH level of dystrophic muscle proteins to normal values (Hill et al. 1976) .
Glyceraldehyde 3-phosphate dehydrogenase and acetyl phosphatase activity in normal and dystrophic muscle: An attempt was made to correlate the alterations in protein sulphydryl content with enzymatic activities by comparing an enzyme with reactive sulphydryl groups (SH), namely, glyceraldehyde 3-phosphate dehydrogenase, and an enzyme with only disulphide bonds (S-S), acetyl phosphatase. Glyceraldehyde 3-phosphate dehydrogenase was chosen because it is a key glycolytic enzyme which is involved in the generation of high energy phosphate for the subsequent production of ATP and phosphocreatine. Moreover, this dehydrogenase has the most sensitive SH groups of all glycolytic enzymes and is, therefore, the most readily inhibited by oxidizing agents. In Duchenne dystrophy, this enzyme is inactivated more rapidly than 15 other enzymes in the glycolytic pathway and Krebs cycle (Heyck & Laudahn 1967) .
Dehydrogenase assays were performed no extracts from the one-year-old chickens used in the sulphydryl determinations. On the basis of Statistical analysis of the treatment showed a P value of 0.03 when comparing the treated and untreated dystrophic males. This suppression did not result from an inhibition of plasma CPK by the drug. Added penicillamine at concentrations as high as 50 mmol had no inhibitory effect on the CPK assay system. There was no significant difference in the plasma CPK activity of untreated and penicillamine-treated normal chickens.
Sulphydryl (SH) levels of proteins in normal and dystrophic muscle extracts: In order to study the mechanism of drug action, the effects of penicillamine treatment on the sulphydryl content of proteins and various enzyme activities are currently under investigation. Penicillamine, as a sulphydryl compound with reducing properties, could alter the sulphydryl content of proteins by disulphide interchange or chelation with divalent metals. For the experimental determinations of titratable sulphydryl groups of soluble muscle proteins, the extracts from 5 normal and 5 dystrophic birds were assayed in the presence of 6 mol guanidine ( Table 2 ). As we have previously shown (Patnode et al. 1976 ), at the age of one year, dystrophic white muscle (pectoral) had only 18 % of the normal amount of SH groups per gram of muscle. On the basis of SH groups per mg of protein, dystrophic muscle had 53% of normal levels, indicating that there was a preferential loss of proteins with measurable sulphydryl (Table 3) . Activity per mg protein (specific activity) of the dystrophic samples was 25% that of normal (P values of 0.002 or less). When normal red and white dehydrogenase activities were compared, the red muscle had only 11 % of the white value on the basis of gram wet weight and 17% of the specific activity. In dystrophic red muscle, the dehydrogenase is not as inhibited as in dystrophic white fibers.
Our recent studies with penicillamine treatment indicate that the dehydrogenase activity in white dystrophic muscle is retained but not completely restored to normal values (Hill et al. 1976 ). The specific activity of treated birds at four months was preserved at about 75 % of normal activity values. Statistically, this was a highly significant improvement when compared with untreated dystrophic birds, as indicated by a P value of0.0002.
In contrast to the dehydrogenase, the specific activity of acetyl phosphatase was slightly increased to 135% of normal values (Table 4) . This indicates a small preferential retention of this enzyme as the dystrophic muscle is 'leaking' other enzymes. The activity per gram of muscle was somewhat decreased but not in accordance with the overall loss of soluble proteins from the dystrophic muscle fibers. Red muscle shows a similar pattern for acetyl phosphatase activity, but the changes are again less pronounced than in the white muscle. Thus acetyl phosphatase with its stabilizing disulphide bonds is more resistant to inactivation than the dehydrogenase. Moreover, penicillamine treatment of the dystrophic birds does not affect the acetyl phosphatase levels in either white or red muscle.
Discussion
Therapeutic evaluation: Penicillamine treatment of avian muscular dystrophy has been shown to have four beneficial effects: (1) Improved righting ability from the supine position, (2) greater wing flexibility, (3) lowered plasma CPK level, and (4) return of enzyme levels in muscle towards normal. Since avian dystrophy can be considered as a model for Duchenne dystrophy, penicillamine might also affect some of the parameters in patients.
The improvement in wing flexibility may be extrapolated to considerations of muscle contractures observed in human dystrophy. If penicillamine treatment were also able to increase limb flexibility in human disease, it may be of clinical interest. Prevention of contractures in Duchenne patients might facilitate arm or hand movements and might also prolong the period of walking.
Another observation of potential clinical interest is that early administration of penicillamine may be important. Penicillamine treatment has been started on the 9th, 27th, and 61st day after hatching. The greatest improvement in righting ability and wing flexibility was found when treatment was started on the 9th day. The effectiveness of the drug diminished accordingly by initiation of treatment on the 27th or 61st day.
Pathogenesis and mechanism of drug action: The present findings offer supportive evidence for the involvement of sulphydryl residues in the pathogenesis of muscular dystrophy and the mechanism of penicillamine action. In addition to glyceraldehyde 3-phosphate dehydrogenase, other glycolytic enzymes such as hexokinase, phosphofructokinase, and CPK require sulphydryl groups for maximal activity (Mahowald et al. 1962) and are inactivated in dystrophic muscle. Penicillamine may protect these thiol enzymes and thereby promote more efficient production of adenosine 5'-triphosphate (ATP) and phosphocreatine.
In dystrophic chickens, the white fibers, which depend primarily on glycolysis for ATP, are more severely affected than the red fibers. Since the red muscle derives most of its ATP from mitochondrial enzymes via oxidative phosphorylation, these membrane-bound enzymes may be structurally protected from inactivation. In addition, the high rate of oxidative metabolism in red muscle may protect sulphydryl enzymes by removal of damaging intracellular oxidants such as peroxides, superoxide anion, and free radicals.
The beneficial effects of penicillamine on joint flexibility may be related to its action on the deposition and cross-linking of collagen. This drug blocks the formation of new insoluble collagen, degrades a certain fraction of recently synthesized insoluble collagen, and inhibits crosslinking (Nimni 1968 , Nimni et al. 1969 ). These properties may alleviate tendon rigidity and prevent infiltration of diseased muscle by collagen. The greater improvement in flexibility associated with the early treatment of the chicks may also be explained by the fact that the amount of degradation of preformed collagen in penicillaminetreated rats is greater in younger animals (Nimni etal. 1969) .
Although the mechanism of drug action has not been fully clarified, these studies may be useful for future investigations on the pathogenesis and treatment of human dystrophy.
